San Francisco, CA, United States of America

Bittoo Kanwar

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 12.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2021-2022

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Bittoo Kanwar: Pioneering Interleukin Delivery Systems

Introduction

Bittoo Kanwar, based in San Francisco, CA, is an innovative inventor known for his contributions to the field of biotechnology. With a focus on interleukin production and purification, he has garnered recognition for his work in developing therapeutic proteins aimed at improving health outcomes.

Latest Patents

Kanwar holds two patents, the latest of which revolves around cholix-IL-10 fusion proteins. His patent describes methods and formulations that are characterized by unique responses in individuals when administered. These responses include notable changes in levels of various markers and the co-localization of IL-10 in the lamina propria.

Moreover, the patent outlines the development of oral formulations of cholix-IL-10 fusion proteins aimed at site-specific release in the small intestines or colon. The methods described also include purification techniques for IL-10 delivery constructs that maintain high biologically active dimer forms, emphasizing the potential effectiveness of these therapeutic proteins.

Career Highlights

Bittoo Kanwar is currently associated with Applied Molecular Transport Inc., where he plays a significant role in his research and development efforts. His background in innovative protein formulations positions him as a key player in advancing therapeutic interventions in the biotechnology sector.

Collaborations

At Applied Molecular Transport Inc., Kanwar collaborates with talented colleagues such as Derek Maclean and Randall J. Mrsny. Together, they are pushing the boundaries of biopharmaceutical development, enhancing the potential of interleukin therapies.

Conclusion

In summary, Bittoo Kanwar is a noteworthy inventor whose work significantly impacts biotherapeutic approaches. With his patents focused on cholix-IL-10 fusion proteins and methods for efficient protein delivery, he continues to shape the landscape of biotechnology and interleukin research, promising advancements that could improve patient care and treatment options.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…